SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-048163
Filing Date
2022-08-31
Accepted
2022-08-31 17:40:45
Documents
1
Period of Report
2022-08-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1476
  Complete submission text file 0001209191-22-048163.txt   3128
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Issuer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RUBRIC CAPTIAL MANAGEMENT LP 155 EAST 44TH ST., SUITE 1630 NEW YORK NY 10017
Business Address
Roberts Justin Hunter (Reporting) CIK: 0001944395 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-00100 | Film No.: 221218973